生物活性 | |||
---|---|---|---|
描述 | G protein-coupled receptor 119 (GPR119), a class A G protein-coupled receptor (GPCR), is involved in regulating metabolic homoeostasis, with GPR119 agonists targeted for the treatment of type-2 diabetes and obesity. MBX-2982 is a selective, orally-available GPR119 agonist. In cells pretreated with MBX-2982 (1 μM) in “chronic incubation/washout” experiments, cAMP accumulation was significantly increased compared to control cells and the sustained response after “chronic incubation/washout” was high at 84.62 ± 20.22% of acute response. In GLUTag cells, MBX-2982 (1 μM; 120 min) evoked a statistically significant increase in GLP-1 secretion compared to control cells[3]. In C57BL/6 mice, MBX-2982 at a dose of 10 mg/kg increased the plasma GLP-1 levels without a glucose load[4]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.23mL 0.45mL 0.22mL |
11.15mL 2.23mL 1.11mL |
22.29mL 4.46mL 2.23mL |
参考文献 |
---|